Seegene, Inc.
Research Seegene, Inc. (096530.KQ) on Bullrun: market cap KRW 1.72T, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker096530.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 1.72T
- Dividend yield2.7%
- Financial periodQ2 2026
- RevenueKRW 135.96B
- Net incomeKRW 25.94B
- Free cash flowKRW 6.81B
- Gross margin69.7%
Valuation Snapshot
latest market cap is KRW 1.72T; dividend yield is 2.7%.
Peer valuation comparison
Latest dividend yield is 2.65% versus a Healthcare sector median of 2.4% (10.4% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 1.72T | n/a | 3.2% | 1200 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1200 KRW, yield 2.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1000 KRW |
About Seegene, Inc.
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Seegene, Inc.'s market cap?
Seegene, Inc.'s market capitalization is KRW 1.72T.
Does Seegene, Inc. pay a dividend?
Seegene, Inc. has a dividend yield of 2.7%.
What does Seegene, Inc. do?
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products.